Ruti Aga's Six-Year Ban: A Non-Existent Clinic, an Old Prescription Pad, and the Misread Glucocorticoid

When the Athletics Integrity Unit's statement landed on my Pune desk last Thursday, my eye did not stop at the number the whole world was reading. Six years. What stopped me was a sentence buried in the middle of the release — a half marathon won in China in March, a positive sample, and then an 'old prescription pad taken from a former employer.' The slip was issued in the name of a clinic that did not exist. The person who wrote it was a family member, not a registered physician. The clinic later disowned the pad entirely. My tea had gone cold. Every prescription leaves a paper trail, and I read the paper before the shouting starts.

The real story here is not that a marathoner was caught. The real story is which substance she was caught on, and how the media mislabelled it. The day a reader does not learn that methylprednisolone is a glucocorticoid and not an anabolic steroid, every number downstream of this debate flows in the wrong direction.

Ruti Aga is an Ethiopian marathoner, thirty-two years old. Her name belongs to the generation that made running around 2:20 ordinary. The 2026 Tokyo Marathon title is hers. Second at Berlin 2026, in roughly 2:18:34 — that figure comes from my own old ledger, not from the source article, so I am treating it as pending verification. Three second-place finishes at World Marathon Majors. On paper this is a solid, deeply respected career.

In March she won a half marathon in China. The time of that race is nowhere in the source — no splits, no field quality, no weather. A post-race sample returned methylprednisolone. The first sanction was two years. Then the prescription submitted during investigation turned out to be forged. A second sanction for tampering: four years. Add them and you get six. The ban runs from 10 September, the same date she was provisionally suspended.

Now look at the numbers. Two plus four sounds simple. It is not. Understand the structure of the Code. When a substance falls in the 'Specified' class, an athlete gets a genuine opportunity to show the intent was not to cheat — and the standard two-year period can then be reduced. Here the two years stood. The panel rejected the no-significant-fault route. Then a separate tampering sanction attached. That is the four. The panel evidently did not find proven intent on the substance, but found full culpability on the documents.

I carry a habit from the 2026 Russia World Cup desk — chai, spreadsheets, and a stubborn refusal to guess. On that desk we logged 64 matches, and every time someone said 'the team looks tired,' we asked: in which minute, in which phase, from which position. The same method applies here. The four years were not built from a mood; they were built from three concrete verification failures.

Failure one: the clinic's existence. The clinic named on the prescription did not exist. Failure two: the practitioner's registration. The person who wrote it had no medical registration and was a family member of the athlete. Failure three: the pad's provenance. They claimed an old pad from a former workplace; the clinic stated plainly that it was not theirs. Three independent checks, three backfires. This is not a filing error; it is a portrait of a medical-governance structure in which an athlete runs without a creditable team physician.

This is where the real technical hinge sits, and this is the information the reader does not have. The source article calls methylprednisolone a 'prohibited steroid' and says WADA classes it as performance enhancing. That classification is imprecise. Methylprednisolone is a glucocorticoid — WADA Prohibited List class S9, not the S1 anabolic agent. And the S9 rule flips the whole arithmetic of the case: these substances are prohibited in-competition only, and only when taken by injection, oral or rectal routes. A knee injection given out of competition is not, by itself, a violation.

The direct consequence is that the pivot of this entire case is not 'steroid use' but route of administration and timing relative to the race. In road events, the testing window opens at 23:59 the night before the race. An injection given days earlier is caught. This is not a detail to forget — it is a straight question of washout timing, the kind a competent team physician writes into every athlete's diary.

Had Aga held genuine medical records, her defence had a legitimate path — intra-articular injection for knee synovitis is standard sports-medicine practice in distance runners. The records were not there. A forged prescription was. And that is the paradox: the paper that was meant to save her is the paper that sank her, because when the treatment is real, nobody forges the prescription.

There is another facet of the sanction that people skim past. The ban is backdated to 10 September, the date the provisional suspension began. This is often presented as a relief. It is not. Counting investigation days against the ban is no benefit to the athlete; it is an accounting entry. Six years at thirty-two means a return at nearly thirty-eight. In Ethiopian women's marathon, where a 2:18 runner is not automatically selected, a thirty-eight-year-old returning with a doping record has a practically closed road. Not a sports ban — a career end.

One thing I should state plainly, because a ledger-keeper must write down his own limits. My ledger cannot give you the time of that race, because it was never recorded; it cannot give you the depth of the field; it cannot tell you when her knee began to fail. The result and prize money from that Chinese half marathon are — by standard AIU practice — very likely annulled, but the statement does not say so. Her 2026 Tokyo title does not automatically fall, because the violation is anchored to a later March race and no finding of earlier use is recorded. What the ledger cannot see, I will not fill with guesswork.

Now the turn where I have to fight my own habit. I am the man who hunts the counter-intuitive read, but my own rule is this: when the boring number is true, publish the boring number.

The boring number is this — the six years were built not from her substance but from her own paperwork. Without the forged prescription, the case likely resolves at two years, or less, on a knee-injury and route-timing explanation. A tampering sanction is standard in every major code. AIU opened no new door here; Aga closed the window on her own defence.

But there is a second, less-heard point, and hiding it would be dishonest. Six years for a glucocorticoid with no proven endurance benefit is, in itself, an unusual sanction. It is used to reduce knee swelling so a runner can compete; it does not build muscle, does not raise red cells, does not improve oxygen carriage. When that classification nuance is placed in the first line, the debate over whether adding four years of document-tampering on top of a substance sanction to reach six is proportionate will still run. I will not deliver a verdict. I will say this — the number will be cited from both sides, by those who praise AIU rigour and by those who allege severity against African road runners. And the number stays the same even when someone is bending it their way.

Here is another question nobody asked. A family member wrote the prescription — that is in the statement. But her agent, her manager, her training camp? No name. Who advised or accepted the forged slip? In the group model of Ethiopian road racing, where several athletes share one cluster, one agent and one informal medical network, this case does not look solitary. Two-year substance findings plus four-year document tampering have become a recognisable category. The enforcement frontier has shifted from detection to verification. Catching was hard; now checking the paperwork is harder.

China's label-race circuit is exactly the ground where this collision happens. Deep East African elite fields, large appearance-fee budgets, and rising AIU testing meet on the same start line. For the runner with an agent, a physician, a washout calendar and a habit of keeping records, this circuit is income. For the one without, it is a trap. A clinic that does not exist, a practitioner without registration, a pad described as old — any one of the three could have been stopped if a creditable physician had stood in the room.

Next time someone writes about a prohibited substance, ask: which class, which route, in-competition or out, and how many hours before the race. Those four questions separate classification from emotion. And when you read about a forged prescription, ask: if the treatment were real, why forge the slip?

The next signal in this case is not what the number six turns out to be. It is whether the March race result and prize money are officially annulled; whether any investigation touches the agent or management; and whether this paper case ever stands at the CAS door. The rest is the arithmetic of six. Arithmetic can be counted again.